CI
Cavalier Investments’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.4M | Sell |
50,288
-53,550
| -52% | -$5.75M | 1.64% | 15 |
|
2025
Q1 | $10.5M | Sell |
103,838
-74,593
| -42% | -$7.52M | 3.56% | 9 |
|
2024
Q4 | $15.9M | Buy |
178,431
+106,590
| +148% | +$9.52M | 5.33% | 4 |
|
2024
Q3 | $6.02M | Buy |
71,841
+4,485
| +7% | +$376K | 1.85% | 14 |
|
2024
Q2 | $5.19M | Buy |
67,356
+2,015
| +3% | +$155K | 1.6% | 12 |
|
2024
Q1 | $4.48M | Buy |
65,341
+3,651
| +6% | +$250K | 1.63% | 18 |
|
2023
Q4 | $3.57M | Buy |
61,690
+1,497
| +2% | +$86.5K | 1.31% | 23 |
|
2023
Q3 | $3.18M | Buy |
60,193
+21,615
| +56% | +$1.14M | 1.24% | 23 |
|
2023
Q2 | $2.09M | Buy |
+38,578
| New | +$2.09M | 0.76% | 35 |
|
2019
Q2 | – | Sell |
-30,219
| Closed | -$1.16M | – | 118 |
|
2019
Q1 | $1.16M | Hold |
30,219
| – | – | 0.48% | 59 |
|
2018
Q4 | $1.07M | Buy |
+30,219
| New | +$1.07M | 0.34% | 58 |
|